Home › Funds › MACKAY SHIELDS LLC › DXCM
MACKAY SHIELDS LLC position in DXCM
DEXCOM INC · Health Care
MACKAY SHIELDS LLC reported holding 22,472,000 shares of DXCM (DEXCOM INC) in its Q3 2026 13F filing — a position valued at US$21.3M, representing 0.88% of its reported portfolio and ranking #49 among its reported holdings. MACKAY SHIELDS LLC has disclosed DXCM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR
How MACKAY SHIELDS LLC's DXCM position evolved
MACKAY SHIELDS LLC first disclosed a stake in DXCM in Q3 2023 at 40,394,000 shares (US$38.2M). The position peaked in Q1 2024 at 41,732,000 shares, worth US$45.9M. Across 13 filings, MACKAY SHIELDS LLC increased the stake 2 time(s), trimmed it 7 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 22,472,000 shares valued at US$21.3M. Notable position changes include a 41% trim in Q1 2025 (shares rose 23% over the following quarter), a 58% increase in Q2 2025 (shares fell 20% over the following quarter), a 25% trim in Q2 2026 (shares rose 28% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 40.39M | $38.24M | New |
| Q4 2023 | 41.96M | $43.98M | Add |
| Q1 2024 | 41.73M | $45.94M | Reduce |
| Q2 2024 | 41.46M | $41.60M | Reduce |
| Q3 2024 | 41.29M | $39.38M | Hold |
| Q4 2024 | 40.40M | $39.02M | Reduce |
| Q1 2025 | 23.72M | $23.11M | Reduce |
| Q2 2025 | 37.47M | $35.30M | Add |
| Q3 2025 | 37.29M | $34.03M | Hold |
| Q4 2025 | 36.91M | $33.98M | Reduce |
| Q1 2026 | 29.97M | $27.63M | Reduce |
| Q2 2026 | 22.41M | $20.92M | Reduce |
| Q3 2026 | 22.47M | $21.27M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DXCM and 13F data
DXCM (DEXCOM INC) is a Health Care company. 27 other funds we track also report a position in DXCM — the largest reported positions include Baillie Gifford & Co (US$996.9M), Castle Hook Partners LP (US$260.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DXCM
- Baillie Gifford & Co 14.80M sh · $996.89M · Q2 2026
- Castle Hook Partners LP 3.87M sh · $260.67M · Q2 2026
More on MACKAY SHIELDS LLC
FAQ
How long has MACKAY SHIELDS LLC held DXCM?
MACKAY SHIELDS LLC has disclosed DXCM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is MACKAY SHIELDS LLC's current position in DXCM?
As of Q3 2026, MACKAY SHIELDS LLC holds 22.47M shares of DXCM (DEXCOM INC), valued at $21.27M, representing 0.88% of its reported portfolio and ranking #49.
Has MACKAY SHIELDS LLC been buying or selling DXCM?
In the latest 13F filing (Q3 2026), MACKAY SHIELDS LLC held unchanged its position in DXCM. The position peaked in Q1 2024 at 41.73M shares.
Which other funds hold DXCM?
Other major institutional holders of DXCM include Baillie Gifford & Co, Castle Hook Partners LP, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.